With insiders buying shares at these lofty levels of the market, it’s a good bet they are very positive on their companies going forward. That's a bullish sign for stock investors as we wrap…
While the selling was robust, it certainly wasn’t extraordinary, and it should be expected given the big run in the markets this year.
While at the end of the day nobody knows exactly what the final action will be in regards to Obamacare, one thing is for sure: things are going to change at some level.
Friday's top analyst upgrades, downgrades and initiations include Apple, Biogen, FedEx, General Electric and Las Vegas Sands.
24/7 Wall St. has screened the Merrill Lynch US 1 list and found five companies that could be poised to outperform in the coming year.
Five stocks are rated Top Picks at Deutsche Bank, and all make good sense for aggressive accounts looking to stay long the chip area.
Given the big run in the stocks, the analysts look to be favoring companies that also have a strong capital markets business. These five that are still rated Buy at Deutsche Bank.
Thursday’s top analyst upgrades, downgrades and initiations include Advanced Micro Devices, Comerica, General Mills, Mastercard and Vertex Pharmaceuticals.
While these are not the highest yielding energy MLPs, they all have some serious upside to the Credit Suisse target prices.
These stocks are rated Buy at Merrill Lynch, pay a dividend and haven’t gone parabolic this year. They make good sense for investors now.
Investors looking for solid growth ideas should consider the huge possibilities for technology infrastructure, due to the massive growth in cloud computing, storage and security.
The team at Merrill Lynch has seen the writing on the wall and raised price targets once again on four steel stocks rated Buy.
The time has come for the Federal Reserve to start raising rates again. Certain sectors tend to either benefit from rising rates or are not affected much.
Monday’s top analyst upgrades, downgrades and initiations include Advanced Micro Devices, CVS Health, ConocoPhillips, EOG Resources, Seattle Genetics and WebMD.
A series of new Jefferies reports focus on four biotech stocks that have big upside potential, regardless of the political chatter.
Solid insider buying into the teeth of one of the biggest rallies in years is a very bullish sign. Insiders would not be willing to risk capital at this level if they were not…
It's not a bit surprising to see insiders take advantage of the huge rally. All the trades we saw this past week seem very orderly, and many of these companies are trading at or…
These companies could be poised to benefit from an improving economy, and some for the potential spending from a massive infrastructure works project.
Friday’s top analyst upgrades, downgrades and initiations include Alliance Data, Autodesk, Biogen, Broadcom, Delta Air Lines and Finisar.
A new JPMorgan research report points to the OPEC production cut as a catalyst for next year, and overall the firm is reasonably bullish for 2017.
